INDOCO REMEDIES LTD. - Announcement Under Regulation 30 (LODR)- Updates (USFDA Inspection At Indoco Remedies Limited'S Plant II (Sterile Facility) And Plant III (OSD Facility) At Goa)

Download	< Back
01 Mar 2023
We would like to inform you that the United States Food and Drug Administration (USFDA) has conducted GMP inspection of Plant II (Sterile Facility) and Plant III (OSD Facility) at Goa. The inspection was conducted from 20th February, 2023 to 28th February, 2023. The USFDA has issued Form 483 with four (4) observations, which will be addressed within stipulated time. We believe that this will not have an impact on the supplies and the existing revenues from these Facilities. The Company is committed to maintain compliances across all our facilities with cGMP quality standards at all times. This is for your information and record.
View all announcements for INDOCO REMEDIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us